ESPR
Esperion Therapeutics Inc
Price:  
1.04 
USD
Volume:  
3,063,583.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR Relative Valuation

-1354.4%
Upside

As of 2025-06-24, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (13.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.04 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -1354.4%.

The range of the Relative Valuation is (11.44) - (14.77) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.4x - 22.4x 17.8x
Forward P/E multiples 14.8x - 19.1x 16.0x
Fair Price (11.44) - (14.77) (13.05)
Upside -1200.1% - -1519.8% -1354.4%
1.04 USD
Stock Price
(13.05) USD
Fair Price

ESPR Relative Valuation - Historical P/E Data

Date P/E
2025-06-23 -1.35
2025-06-20 -1.38
2025-06-18 -1.42
2025-06-17 -1.41
2025-06-16 -1.51
2025-06-13 -1.51
2025-06-12 -1.55
2025-06-11 -1.57
2025-06-10 -1.58
2025-06-09 -1.55
2025-06-06 -1.58
2025-06-05 -1.50
2025-06-04 -1.45
2025-06-03 -1.36
2025-06-02 -1.19
2025-05-30 -1.10
2025-05-29 -1.13
2025-05-28 -1.08
2025-05-27 -1.06
2025-05-23 -1.02
2025-05-22 -1.04
2025-05-21 -1.10
2025-05-20 -1.18
2025-05-19 -1.12
2025-05-16 -1.04
2025-05-15 -1.01
2025-05-14 -0.94
2025-05-13 -1.01
2025-05-12 -1.03
2025-05-09 -1.03
2025-05-08 -1.15
2025-05-07 -1.13
2025-05-06 -1.26
2025-05-05 -1.36
2025-05-02 -1.41
2025-05-01 -1.27
2025-04-30 -1.29
2025-04-29 -1.24
2025-04-28 -1.17
2025-04-25 -1.19
2025-04-24 -1.14
2025-04-23 -1.23
2025-04-22 -1.20
2025-04-21 -1.10
2025-04-17 -1.23
2025-04-16 -1.25
2025-04-15 -1.29
2025-04-14 -1.29
2025-04-11 -1.32
2025-04-10 -1.24